Moolec Science S.A.
MLEC · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $41 | $427 | $1,268 | $375 |
| - Cash | $1 | $5 | $3 | $1 |
| + Debt | $247 | $15 | $3 | $0 |
| Enterprise Value | $287 | $436 | $1,268 | $374 |
| Revenue | $334 | $6 | $1 | $0 |
| % Growth | 5,830.7% | 521.5% | – | – |
| Gross Profit | $114 | $0 | -$0 | $0 |
| % Margin | 34.2% | 8.4% | -15.8% | – |
| EBITDA | -$69 | -$6 | -$52 | -$4 |
| % Margin | -20.7% | -109.5% | -5,717% | – |
| Net Income | -$111 | -$7 | -$52 | -$5 |
| % Margin | -33.4% | -130% | -5,722.2% | – |
| EPS Diluted | -258.75 | -2.85 | -22.5 | -1.8 |
| % Growth | -8,978.9% | 87.3% | -1,150% | – |
| Operating Cash Flow | -$24 | -$9 | -$8 | -$2 |
| Capital Expenditures | -$6 | -$0 | -$0 | $0 |
| Free Cash Flow | -$30 | -$9 | -$8 | -$2 |